<DOC>
	<DOC>NCT00847613</DOC>
	<brief_summary>This study is designed to provide safety and efficacy data to support the development of CP-690,550 in patients with moderate to severe rheumatoid arthritis on background of methotrexate.</brief_summary>
	<brief_title>A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>Adults with moderate to severe rheumatoid arthritis on a stable dose of methotrexate Pregnancy, severe acute or chronic medical conditions, including serious infections or clinically significant laboratory abnormalities.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>double-blind placebo-controlled investigational drug oral therapy safety and efficacy hand and feet x-rays</keyword>
</DOC>